Tecon Biology Co.Ltd(002100) : Tecon Biology Co.Ltd(002100) non public offering report and listing announcement

Stock Code: 002100 stock abbreviation: Tecon Biology Co.Ltd(002100) listing place: Shenzhen Stock Exchange bond Code: 128030 bond abbreviation: Tiankang convertible bond listing place: Shenzhen Stock Exchange Tecon Biology Co.Ltd(002100)

Non public offering of a shares

of

Issuance report and listing announcement

Sponsor (lead underwriter)

December, 2001

statement

The company and all directors undertake that there are no false records, misleading statements or major omissions in the contents of this issuance report, listing announcement and its abstract, and bear individual and joint legal liabilities for its authenticity, accuracy and completeness.

Signatures of all directors:

Yang Yancheng Hui Xu Zhenhua

Guo Yunjiang, Geng Lixin, Yang Lifang

Bian Xinjun and Shan genqiang

Tecon Biology Co.Ltd(002100) mm / DD / 2021

hot tip

1、 Issue quantity and price

(i) Number of shares issued: 277449664

(2) Issue price: 7.45 yuan / share

(3) Nature of issued shares: RMB ordinary shares (A shares), tradable shares with restricted sales conditions

(4) Total funds raised: RMB 2066999996.80

(5) Net amount of raised funds: RMB 2043263919.66

2、 New stock listing arrangements

277449664 new shares will be listed on Shenzhen Stock Exchange on December 24, 2021. On the first day of listing of new shares, the company’s share price does not ex right, and the stock trading is subject to rise and fall restrictions. 3、 Issuance and subscription and arrangement of restricted sale period

Serial number name of issuing object number of shares subscribed amount (yuan) proportion of subscribed amount in total share capital after issuance (shares)

1. Huaxia Fund Management Co., Ltd. 8859065999997.000 65%

2JPMorgan Chase Bank, National9,771,81272,799,999.400. 72%Association

3. China Southern Fund Management Co., Ltd. 1154362485999998.800 85%

4 Zhang Haiyan 805369159999997.950 59%

5 Penghua Fund Management Co., Ltd. 2214765116499999.951 64%

6 Harvest Fund Management Co., Ltd. 6477852348259996.354 78%

7 CAITONG Fund Management Co., Ltd. 31946308237999994.602 36%

8 China Galaxy Securities Co.Ltd(601881) 39,127,516291,499,994.202. 89%

9 Guotai Junan Securities Co.Ltd(601211) 11,382,55084,799,997.500. 84%

10 Nord Fund Management Co., Ltd. 16308724149993.801 20%

11 Xinjiang Jintou Asset Management Co., Ltd. 805369159999997.950 59%

12 GF Fund Management Co., Ltd. 4547651433880029.303 36%

Total 2774496642066999996.8020 49%

According to the relevant provisions of the China Securities Regulatory Commission and Shenzhen Stock Exchange, the shares subscribed by the issuing object for this non-public offering shall not be transferred within 6 months from the date of completion of the offering. After the end of the restricted sale period, the transfer of the shares subscribed by the issuing object will be implemented in accordance with the company law of the people’s Republic of China and other relevant laws and regulations, as well as the relevant provisions of the CSRC and Shenzhen Stock Exchange. 4、 Ownership structure

After the completion of this non-public offering, the equity distribution of the company meets the listing conditions specified in the stock listing rules of Shenzhen Stock Exchange.

catalogue

Declare that 1 special tips one

1、 Issue quantity and price one

2、 New stock listing arrangements one

3、 Issuance and subscription and arrangement of restricted sale period one

4、 Ownership structure 2 catalog 3 interpretation Section 1 basic information of this offering five

1、 Basic information of the issuer five

2、 Relevant procedures performed in this offering five

3、 Basic information of this offering seven

4、 Basic information of the issuing object eleven

5、 Relevant institutions of this issuance Section II listing of new shares twenty

1、 Approval for listing of new shares twenty

2、 Securities abbreviation, securities code and listing place of new shares twenty

3、 Listing time of new shares twenty

4、 Restrictions on the sale of new shares Section III comparison of relevant situations of the company before and after this issuance twenty-one

1、 Comparison of relevant situations before and after this issuance twenty-one

2、 The impact of this non-public offering on the company Section IV financial accounting information of the issuer and management discussion and Analysis twenty-five

1、 Description of the company’s main financial data and preparation basis of financial indicators twenty-five

2、 Main financial data and financial indicators for the last three years twenty-five

3、 Management discussion and Analysis Section V recommendation institutions (lead underwriter) concluding comments on the process of this non-public offering and the compliance of the issuing object…… 31 section VI concluding comments of the issuer’s lawyer on the process of this non-public offering and the compliance of the issuing object…… 32 Section VII recommendation on the listing of the sponsor…… 33 Section VIII statement on intermediaries…… 34 section IX documents for future reference…… 39

interpretation

Unless otherwise specified, the following words in this issuance report have the following specific meanings:

Issuer / company / Tecon Biology Co.Ltd(002100) means Tecon Biology Co.Ltd(002100)

The controlling shareholder, the state-owned assets company of Xinjiang production and Construction Corps, actually refers to the State-owned Assets Management Co., Ltd. of Xinjiang production and Construction Corps

Controller

A shares / ordinary shares / shares refer to Tecon Biology Co.Ltd(002100) RMB ordinary shares listed on Shenzhen stock exchange with a par value of RMB 1 per share

This non-public offering / this offering refers to Tecon Biology Co.Ltd(002100) issuing A-Shares to no more than 35 specific objects to raise funds through non-public offering

This issuance report and listing announcement refer to the issuance report and listing announcement of Tecon Biology Co.Ltd(002100) non public Development Bank A shares

General meeting means Tecon Biology Co.Ltd(002100) general meeting of shareholders

Board of directors means the Tecon Biology Co.Ltd(002100) board of directors

CSRC / CSRC means China Securities Regulatory Commission

Registration company refers to Shenzhen Branch of China Securities Depository and Clearing Co., Ltd

Shenzhen stock exchange refers to Shenzhen Stock Exchange

Trading day refers to the trading day of Shenzhen Stock Exchange

The Company Law refers to the company law of the people’s Republic of China, which is applicable and effective

Securities Law refers to the securities law of the people’s Republic of China, which is applicable and effective

The measures for the administration of securities issuance refer to the measures for the administration of securities issuance by listed companies

The detailed rules for the implementation of non-public development banks refer to the detailed rules for the implementation of non-public development banks of listed companies

Articles of association means the Tecon Biology Co.Ltd(002100) articles of association

Sponsor / lead underwriter / China Securities Co.Ltd(601066) / refers to China Securities Co.Ltd(601066)

China Securities Co.Ltd(601066) securities

Lawyer of the issuer refers to Beijing Zhonglun law firm

Capital verification institution / sigma refers to sigma Certified Public Accountants (special general partnership)

Yuan, ten thousand yuan and one hundred million yuan refer to RMB yuan, ten thousand yuan and one hundred million yuan

Note 1: unless otherwise specified in this issuance report and listing announcement, all values shall retain 2 decimal places. If the total number is inconsistent with the mantissa of the sum of the values of each sub item, it shall be caused by rounding. Note 2: unless otherwise specified, the financial data and financial indicators in this issuance report and listing announcement are consolidated statement data.

Section I basic information of this offering

1、 Basic information of the issuer

Company name Tecon Biology Co.Ltd(002100)

English Name: tecon biology Co.Ltd

Date of establishment: December 28, 2000

Listing date: December 26, 2006

Place of listing: Shenzhen Stock Exchange

Stock abbreviation Tecon Biology Co.Ltd(002100)

Stock Code: 002100 SZ

Legal representative: Yang Yan, Secretary of the board of directors: Guo Yunjiang

The total share capital is 10763342 yuan

Registered address: No. 528, South Changchun Road, Urumqi high tech Industrial Development Zone, Xinjiang

Office address: No. 528, South Changchun Road, Urumqi high tech Industrial Development Zone, Xinjiang

Production and sales of veterinary drugs; Production and sales of feed; Production of additive premixed feed; Production and sales of feed additives; Sales of Holstein cattle (the specific business scope and validity period of the above projects shall be subject to the license issued by relevant departments); import and export business scope of self-supporting and agency of various commodities and technologies (except for the commodities and technologies limited or prohibited by the state); technical consulting services related to the business scope; sales of agricultural and livestock products; edible Shenzhen Agricultural Products Group Co.Ltd(000061) Sales of; Equity investment, sales of agricultural and sideline products; Production and sales of fertilizers; Warehousing. (for projects subject to approval according to law, business activities can be carried out only after approval by relevant departments)

Note: the total share capital of the company changes with the conversion of “Tiankang convertible bonds”. The total share capital of the company as of September 30, 2021 is listed here. According to the announcement on the conversion of convertible corporate bonds in the third quarter of 2021, as of September 30, 2021, the total share capital of the company was 1076334342 shares, and Tiankang convertible bonds were still listed for trading of RMB 88500000. 2、 Relevant procedures to be performed in this offering

(i) Internal decision-making procedures for this issuance

The issuer has performed the following internal decision-making procedures for this non-public offering:

1. On December 29, 2020, the issuer held its seventh meeting

 

- Advertisment -